Pharmacovigilance Newsletter: Issue 1, September 2016

By publishing this newsletter, The Directorate General of Drug Administration (DGDA) will be able to communicate information on the safety of medicines and other health products to health care professionals, consumers, and the public on a regular basis. In the event of an emergency, when serious risks arise, that information will become crucial to ensuring the availability of safe, effective, and quality medicines.

Files for Download: Other Files: